Bio/Pharma News

Nov 20, 2017
By Pharmaceutical Technology Editors
The agency has approved a biologic-based new molecular entity for treating hemophilia A and has expanded the indication for a leukemia drug to now treat a common form of non-Hodgkin lymphoma.
Nov 20, 2017
By Pharmaceutical Technology Editors
Ontruzant is the first biosimilar of Roche’s Herceptin (trastuzumab) to be approved in Europe.
Nov 20, 2017
By Pharmaceutical Technology Editors
The opnME.com platform offers scientists access to best-in-class molecules supported by comprehensive data packages.
Nov 16, 2017
By Pharmaceutical Technology Editors
Bayer will make a $400-million upfront payment to develop and commercialize two anti-cancer compounds in Loxo Oncology’s portfolio.
Nov 16, 2017
By Pharmaceutical Technology Editors
The entities announced that they will partner to improve access to cancer treatments and diagnostics in Ethiopia, Uganda, and Tanzania.
Nov 16, 2017
By Pharmaceutical Technology Editors
As part of the deal, J&J’s Janssen will pay an upfront payment of $50 million to research, develop, and commercialize up to six bispecific antibodies.
Nov 14, 2017
By Pharmaceutical Technology Editors
The agency approved Abilify MyCite, a pill with a sensor that digitally tracks if patients have ingested their medication.
Nov 13, 2017
By Pharmaceutical Technology Editors
The company has appointed Albert Bourla, PhD, as its new COO.
Nov 10, 2017
By Pharmaceutical Technology Editors
The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.
Nov 10, 2017
By Pharmaceutical Technology Editors
The EMA’s Committee for Medicinal Products for Human Use has recommended marketing authorization approval for AstraZeneca’s benralizumab, a monoclonal antibody for treating severe asthma.
native1_300x100
lorem ipsum